Blog

Difficult-to-Treat Rheumatoid Arthritis Resolved in 45% Via Additional Treatment Changes

A June 8, 2024 study titled Five-year follow-up of patients with difficult-to-treat rheumatoid arthritis published in Rheumatology has fascinating results, and Remission Medical providers discussed it in depth in our Grand Rounds meeting last month.

Read More

Difficult-to-Treat Rheumatoid Arthritis Resolved in 45% Via Additional Treatment Changes

Read More

Our Partner, Switchboard Health: Network of Specialty Care

Read More

Remission Medical Launches a Navigator Service

Read More

New Immunotherapy Approach for Autoimmune Diseases

Read More

Remission Medical Partners with Sentara Health to Expand Access to Rheumatology Care

Read More

Trigger in Autoimmune Diseases: Trauma

Read More

Rheumatology telehealth startup strikes deals with Sentara, OrthoVirginia

Read More

A View of Autoimmune Disease from a Patient … and Rheumatologist

Read More

ACR20 Criteria Explained

Read More

Talk Therapy for Fibromyalgia

Read More

Switching to a Biosimilar

Read More

New IV Medication for Psoriatic Arthritis

Read More

Managing Nociplastic Pain in Rheumatic Diseases

Read More

Rheumatologists Help Reduce ED, Hospitalization Costs

Read More

Less Joint Replacement in OA?

Read More

AI in Rheumatoid Arthritis

Read More

Remission Medical enters know-how agreement with Mayo Clinic to transform rheumatology care delivery

Read More

Side Effect Fear in Medication Choice in RA and PsA

Read More

Stalled Clinical Trials in Rheumatology

Read More

Integrative Interventions in Rheumatoid Arthritis

Read More

"Dr. Harner is awesome! He took time to listen and seemed to really care."